Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects

Pharmacopsychiatry

Volumn 32, Issue 1, 1999, Pages 13-20

  Verhoeven, W M A ^a   Tuinier, S ^a   Van den Berg, Y W M M ^a   Coppus, A M W ^b   Fekkes, D ^c   Pepplinkhuizen, L ^c   Thijssen, J H H ^d  

^a VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

^b Saamvliet Inst Mental Retardation   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA CARBOLINE; BETA ENDORPHIN; CORTICOTROPIN; HORMONE BINDING PROTEIN; HYDROCORTISONE; NALTREXONE; NEUROLEPTIC AGENT; OPIATE AGONIST; SEROTONIN; TRYPTOPHAN;

ADULT; ARTICLE; AUTOMUTILATION; CONTROLLED STUDY; FEMALE; HUMAN; HYPERACTIVITY; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STEREOTYPY; STRESS;

EID: 0033017292     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979183     Document Type: Article

References (57)

1. Aman, M. G., N. N. Singh: The Aberrant Behaviour Checklist: a behavior rating scale for the assessment of treatment effects. Am. J. Ment. Deficiency 89 (1985) 485-491
2. Armario, A., M. Giralt, O. Marti, A. Gavalda, J. Hidalgo, B. R. Hsu, R. W. Kuhn: The effect of acute and chronic ACTH administration on pituitary-adrenal response to acute immobilization stress. Relationship to changes in corticosteroid globulin. Endocr. Res. 20 (1994) 139-149
3. Ballenger, J. C, S. McDonald, R. Noyes, K. Rickels, N. Sussman, S. Woods, J. Patin, J. Singer: The first double-blind, placebo controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder. Psychopharmacol. Bull. 27 (1991) 171-179
4. Bodfish, J. W., T. W. Crawford, S. B. Powell, D. E. Parker, R. N. Golden, M. H. Lewis: Compulsion in adults with mental retardation: Prevalence, phenomenology, and co-morbidity with stereotypy and self-injury. Am. J. Ment. Retard. 100 (1995) 183-192
5. Bodfish, J. W., K. M. Newell, R. L. Sprangue, V. N. Harper, M. H. Lewis: Dyskinetic movement disorder among adults with mental retardation: phenomenology and co-occurrence with stereotypy. Am. J. Ment. Retard. 101 (1996) 118-129
6. Branchey, L., M. Branchey, S. Shaw, C S. Lieber: Depression, suicide and aggression in alcoholics and their relationship to plasma amino acids. Psychiatry Res. 12 (1984) 219-226
7. Breyer-Pfaff, U., G. Wiatr, I. Stevens, H. J. Gaertner, G. Mundle, K. Mann: Elevated norharman plasma levels in alcoholic patients and controls resulting from tabacco smoking. Life Sci. 58 (1996) 1425-1432
8. Coenen, C M., C. M. Thomas, G. F. Borm, J. M. Hollanders, R. Rolland: Changes in androgens during treatment with four low-dose contraceptives. Contraception 53 (1996) 171-176
9. Dalin, A. M., U. Magnusson, J. Haggendal, L. Nyberg: The effect of thiopentone-sodium anesthesia and surgey, relocation, grouping, and hydrocortisone treatment on the blood levels of cortisol, corticosteroid-binding globulin, and catecholamines in pigs. J. Anim. Sci. 71 (1993) 1902-1906
10. De Kloet, R. E.: Brain corticosteroid receptor balance and homeostatic control. Frontiers in Neuroendocrinology 12 (1991) 95-164
11. De Kloet, R. E., S. M. Korte, N. Y. Rots, M. R. Kruk: Stress hormones, genotype, and brain organization. Implications for aggression. Ann. N.Y. Acad. Sci. 794 (1996) 179-191
12. Dubovsky, S. L., M. Thomas: Beyond specificity: effects of serotonin and serotonergic treatments on psychobiological dysfunction. J. Psychosom. Res. 39 (1995) 429-444
13. Fekkes, D., W. T. Bode: Occurrence and partition of the β-carboline norharman in rat organs. Life Sci. 52 (1993) 2045-2054
14. Fekkes, D., L. Pepplinkhuizen, R. Verheij, J. Bruinvels: Abnormal metabolism of serine, methionine and taurine in transient acute polymorphic psychosis. Psychiatry Res. 15 (1994) 11-18
15. Fekkes, D., A. Van Dalen, M. Edelman, A. Voskuilen: Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated derivatization with ophthaldialdehyde, J. Chromatogr. B; Biomed. Appl. 669 (1995) 177-186
16. Fekkes, D., L. Timmerman, L. Pepplinkhuizen: Effects of clomipramine on plasma amino acids and serotonergic parameters in panic disorder and depression. Eur. Neuropsychopharmacol. 7 (1997) 235-239
17. Fernstrom, J. D., R. J. Wurtman: Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178 (1972) 414-416
18. Gilberg, C., L. Terenius, G. Linnerholm: Endorphin activity in childhood psychosis. Arch. Gen. Psychiatry 42 (1985) 780-783
19. Gispen-De Wied, C. C., H. G. M. Westenberg, J. H. H. Thijssen: The dexamethasone and cortisol suppression test in depression; β-endorphin as a useful marker. Psychoneuroendocrinology 12 (1987) 355-366
20. Herman, B. H.: A possible role of propiomelanocortin peptides in self-injurious behaviour. Progr. Neuropsychopharmacol. Biol. Psychiatry 14 (1990) S109-S139
21. Jones, I. H., B. M. Barraclough: Auto-mutilation in animals and its relevance to self-injury in man. Acta Psychiatr. Scand. 58 (1978) 40-47
22. Jones, I. H.: Self-injury: Toward a biological basis. Perspect. Biol. Med. 26 (1982) 137-150
23. Kennes, D., F. Odberg, Y. Bouquet, P. H. De Rycke: Changes in naloxone and haloperidol effects during the development of captivity-induced jumping stereotypy in bank voles. Eur. J. Pharmacol. 153 (1988) 19-24
24. Kennett, G. A., G. Curzon, A. Hunt, A. J. Patel: Immobilization decreases amino acid concentrations in plasma but maintains or increases them in brain. J. Neurochem. 46 (1986) 208-212
25. King, B. H.: Self-injury by people with mental retardation: A compulsive behavior hypothesis. Am. J. Ment. Retard. 98 (1993) 93-112
26. Kraemer, G. W., A. S. Clarke: The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Progr. Neuropsychopharmacol. Biol. Psychiatry 14 (1990) 141-168
27. Ktiouet, J., H. Susini de Luca, H. Zouaghi, H. Toure-Saw, C. Benkelfat, H. Lôo: Diminution de l'activité liante de la transcortine (CBG) dans la dépression. L'Encéphale 10 (1984) 215-216
28. Lewis, M. H., J. P. Gluck, J. W. Bodfish, A. J. Beauchamp, R. B. Mailman: Neurobiological basis of stereotyped movement disorder. In: R. L. Sprague, K. M. Newell (Eds.): Stereotyped movements; Brain and behavior relationships. American Psychological Association, Washington (1996a) 37-68
29. Lewis, M. H., J. W. Bodfish, S. B. Powell, K. Wiest, M. Darling, R. N. Golden: Plasma HVA in adults with mental retardation and stereotyped behaviour: biochemical evidence for a dopamine deficiency model. Am. J. Ment. Retard. 100 (1996b) 413-427
30. Maes, M., A. Van Gastel, P. Blockx, M. Martin, P. Cosyns, S. Scharpé, R. Ranjan, R. Desnyder: Lower serum transcortin (CBG) in major depressed females: relationships with baseline and postdexamethasone cortisol values. J. Affective Disord. 38 (1996) 47-56
31. Mittleman, G., G. H. Jones, T. W. Robbins: Sensitization of amphetamine stereotypy reduces plasma corticosterone: Implications for stereotypy as a coping response. Behav. Neural. Biol. 56 (1991) 170-182
32. Moller, S. E., E. L. Mortensen, L. Breum, C. Alling, O. G. Larsen, T. Boge-Rasmussen, C. Jensen, K. Bennicke: Aggression and personality: association with amino acids and monoamine metabolites. Psychol. Med. 26 (1996) 323-331
33. Nagamitsu, S., T. Matsuishi, T. Kisa, H. Komori, M. Miyazaki, T Hashimoto, Y. Yamashita, E. Ohtaki, H. Kato: CSF β-endorphin levels in patients with infantile autism. J. Autism Dev. Disord. 27 (1997) 155-163
34. Noten, J. B. G. M., D. R. A. Uges: Clinical pharmacokinetics of neuroleptic drugs. In: Merkus, F. W. H. M. (Ed): The serum concentration of drugs. Clinical relevance, theory and practice. Excerpta Medica, Amsterdam (1980) 125-133
35. Oliver, C.: Annotation: self-injurious behavior in children with learning disabilities: recent advances in assessment and intervention. J. Child Psychol. Psychiatry 36 (1995) 909-927
36. Petty, F., L. L. Davis, D. Kabel, G. L. Kramer: Serotonin dysfunction disorders: a behavioral neurochemistry perspective. J. Clin. Psychiatry 57 (1996) 11-16
37. Prasad, B. M., B. A. Sorg, C. Ulibarri, P. W. Kalivas: Sensitization to stress and psychostimulants. Involvement of dopamine transmission versus the HPA Axis. Ann. N.Y. Acad. Sci. 771 (1995) 617-625
38. Rommelspacher, H., P. Dufeu, L. G. Schmidt: Harman and norharman in alcoholism: correlations with psychopathology and long-term changes. Alcoholism: Clin. Experim. Res. 20 (1996) 3-8
39. Ruokonen, A., K. Kaar: Effects of desogestel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDT-cholesterol. European J. Obstet. Gynecol. Reprod. Biol. 20 (1985) 13-18
40. Sandman, C A.: β-Endorphin disregulation in autistic and self-injurious behaviour: A neurodevelopmental hypothesis. Synapse 2 (1988) 193-199
41. Sandman, C. A., J. L. Barron, A. Chicz-Demet, E. M. Demet: Plasma B-endorphin levels in patients with self-injurious behavior and stereotypy. Am. J. Ment. Retard. 95 (1990) 84-92
42. Sandman, C A., W. Hetrick, D. V. Taylor, A. Chicz-DeMet: Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. Am. J. Ment. Retard. 102 (1997) 182-199
43. Skolnick, P., S. M. Paul: New concepts in the neurobiology of anxiety. J. Clin. Psychiatry 44 (1983) 12-19
44. Skolnick, P., J. N. Crawley, J. R. Glowa, S. M. Paul: β-Carboline-induced anxiety states. Psychopathology 17 (1984) 52-60
45. Stohler, R., H. Rommelspacher, D. Ladewig, G. Dammann: Beta-carboline (harman norharman) sind bei Heroinabhängigen erhöht. Ther. Umsch. 50 (1993) 178-181
46. Tordjman, S., M. G. Anderson, P. A. McBride, M. E. Hertzig, M. E. Snow, L. M. Hall, S. M. Thompson, P. Ferrari, D. J. Cohen: Plasma beta-endorphin, adrenocorticoptropin hormone, and cortisol in autism. J. Child. Psychol. Psychiatry 38 (1997) 705-715
47. Torpy, D.J., J. E. Grice, G. I. Hockings, G. V. Crosbie, M. M. Walters, R. V. Jackson: Effects of sodium valproate on naloxone stimulated ACTH and cortisol release in humans. Clin. Exp. Pharmacol. Physiol. 22 (1995) 441-443
48. Tuinier, S., W. M. A. Verhoeven: Stress and stereotypy; reflections about its relationship and neurobiological substrate. In: Fletcher, R. J., D. Menelis, L. Fusaro (Eds.): Proceedings International Congres II NADD, (1995) 57-61
49. Tuinier, S., Verhoeven W. M. A., Van Praag H. M.: Serotonin and disruptive behaviour; A critical evaluation of the clinical data. Hum. Psychopharmacol. 11 (1996)469-482
50. Uges, D. R. A., Noten J. B. G. M.: The serum concentration of tricyclic antidepressants. In: Merkus F. W. H. M. (Ed): The serum concentration of drugs. Clinical relevance, theory and practice. Excerpta Medica, Amsterdam (1980) 114-124
51. Van Praag, H. M., Asnis G. M., Kahn R. S., Brown S. L., Korn M., Harkavy Friedman J. M., Wetzler S.: Monoamines and abnormal behaviour. A multi-aminergic perspective. Br. J. Psychiatry 157 (1990) 723-734
52. Verhoeven, W. M. A., Tuinier S.: The psychopharmacology of challenging behaviours in developmental disabilities. In: Bouras N. (Ed.): Psychiatric and behavioral disorders in mental retardation. Cambridge University Press (1998a) in press.
53. Verhoeven, W. M. A., Tuinier S.: Serotonin 1 a agonist buspirone in disruptive behaviour. Acta Psychiatrica Belgica (1998b) in press.
54. Vriend, J. P., Alexiuk N. A.: Effects of valproate on amino acid and monoamine concentrations in striatum of audiogenic seizure-prone Balb/c mice. Mol. Chem. Neuropathol. 27 (1996) 307-324
55. Wiepkema, P. R. and Schouten W. G. P.: Stereotypies in sows during chronic stress. Psychother. Psychosom. 57 (1992) 194-199
56. Weizman, R., I. Gil-Ad, J. Dick, S. Tyano, G. A. Szekely, Z. Laron: Low plasma immunoreactive β-endorphin levels in autism. Am. Acad. Child Adoles. Psychiatry 27 (1988) 430-433
57. Willemsen-Swinkels, S. H. N., J. K. Buitelaar, F. G. Weijnen, J. H. Thijssen, H. Van Engeland: Plasma β-endrophin concentrations in people with learning disability and self-injurious and/or autistic behaviour. Br. J. Psychiatry 168 (1996) 105-109